NCT05626322 2025-09-05Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell LymphomaPfizerPhase 1/2 Terminated6 enrolled 17 charts